Trial intelligence / Profile preview

Jing-Fu-Yau-Yu-Bau Medicated Bath for Psoriasis

NCT04117919Phase 2Unknown

Sponsor
China Medical University Hospital
Start
Oct 2019
Primary completion
Dec 2019
Modality
HM (Herbal Medicine)
Countries
1
01

Overview

Phase 2, randomised, single-blind trial of paper mulberry leaf in plaque psoriasis (2 arms), sponsored by China Medical University Hospital. Primary endpoint: Major or Partial Clinical Response defined by Psoriasis Area Severity Index at 8 weeks. Status: unknown.

02

Drugs

paper mulberry leaf
03

Conditions

plaque psoriasis

Beyond the preview

Go deeper on NCT04117919.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04117919.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call